Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Longitudinal analysis of risk factors for dementia based on Mild Cognitive Impairment Screen results and questionnaire responses from healthy Japanese individuals registered in an online database.

Ogawa M, Maruo K, Sone D, Shimada H, Suzuki K, Watanabe H, Matsuda H, Mizusawa H.

Alzheimers Dement (N Y). 2019 Aug 2;5:347-353. doi: 10.1016/j.trci.2019.06.003. eCollection 2019.

2.

A Comparison Between a Meta-analytic Approach and Power Prior Approach to Using Historical Control Information in Clinical Trials With Binary Endpoints.

Isogawa N, Takeda K, Maruo K, Daimon T.

Ther Innov Regul Sci. 2019 Jul 31:2168479019862531. doi: 10.1177/2168479019862531. [Epub ahead of print]

PMID:
31366216
3.

Multiple imputation for longitudinal data in the presence of heteroscedasticity between treatment groups.

Yamaguchi Y, Ueno M, Maruo K, Gosho M.

J Biopharm Stat. 2019 Jun 29:1-19. doi: 10.1080/10543406.2019.1632878. [Epub ahead of print]

PMID:
31257987
4.

Cognitive behavioral therapy with interoceptive exposure and complementary video materials for irritable bowel syndrome (IBS): protocol for a multicenter randomized controlled trial in Japan.

Kawanishi H, Sekiguchi A, Funaba M, Fujii Y, Yoshiuchi K, Kikuchi H, Kawai K, Maruo K, Sugawara N, Hatano K, Shoji T, Yamazaki T, Toda K, Murakami M, Shoji M, Ohara C, Tomita Y, Fukudo S, Ando T.

Biopsychosoc Med. 2019 Jun 6;13:14. doi: 10.1186/s13030-019-0155-2. eCollection 2019.

5.

Factors associated with the use and longer duration of seclusion and restraint in psychiatric inpatient settings: a retrospective chart review.

Narita Z, Inagawa T, Yokoi Y, Stickley A, Maruo K, Yamada Y, Sugawara N.

Int J Psychiatry Clin Pract. 2019 Apr 29:1-5. doi: 10.1080/13651501.2019.1607878. [Epub ahead of print]

PMID:
31035799
6.

Discrete effect of each mild behavioural impairment category on dementia conversion or cognitive decline in patients with mild cognitive impairment.

Yokoi Y, Takano H, Sakata M, Maruo K, Nakagome K, Matsuda H.

Psychogeriatrics. 2019 Mar 19. doi: 10.1111/psyg.12447. [Epub ahead of print]

PMID:
30891900
7.

Exploratory analyses of effect modifiers in the antidepressant treatment of major depression: Individual-participant data meta-analysis of 2803 participants in seven placebo-controlled randomized trials.

Noma H, Furukawa TA, Maruo K, Imai H, Shinohara K, Tanaka S, Ikeda K, Yamawaki S, Cipriani A.

J Affect Disord. 2019 May 1;250:419-424. doi: 10.1016/j.jad.2019.03.031. Epub 2019 Mar 6.

PMID:
30878654
8.

Efficient two-step multivariate random effects meta-analysis of individual participant data for longitudinal clinical trials using mixed effects models.

Noma H, Maruo K, Gosho M, Levine SZ, Goldberg Y, Leucht S, Furukawa TA.

BMC Med Res Methodol. 2019 Feb 14;19(1):33. doi: 10.1186/s12874-019-0676-1.

9.

Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.

Kotajima-Murakami H, Takano A, Ogai Y, Tsukamoto S, Murakami M, Funada D, Tanibuchi Y, Tachimori H, Maruo K, Sasaki T, Matsumoto T, Ikeda K.

Neuropsychopharmacol Rep. 2019 Jun;39(2):90-99. doi: 10.1002/npr2.12050. Epub 2019 Feb 12.

10.

Development and validation of a prediction model for the probability of responding to placebo in antidepressant trials: a pooled analysis of individual patient data.

Shinohara K, Tanaka S, Imai H, Noma H, Maruo K, Cipriani A, Yamawaki S, Furukawa TA.

Evid Based Ment Health. 2019 Feb;22(1):10-16. doi: 10.1136/ebmental-2018-300073. Epub 2019 Jan 21.

PMID:
30665989
11.

SignalDetDDI: An SAS macro for detecting adverse drug-drug interactions in spontaneous reporting systems.

Gosho M, Ohigashi T, Maruo K.

PLoS One. 2018 Nov 19;13(11):e0207487. doi: 10.1371/journal.pone.0207487. eCollection 2018.

12.

A Meta-Analysis of the Effect of Multisession Transcranial Direct Current Stimulation on Cognition in Dementia and Mild Cognitive Impairment.

Inagawa T, Narita Z, Sugawara N, Maruo K, Stickley A, Yokoi Y, Sumiyoshi T.

Clin EEG Neurosci. 2019 Jul;50(4):273-282. doi: 10.1177/1550059418800889. Epub 2018 Sep 19.

PMID:
30229671
13.

National registry of patients with Fukuyama congenital muscular dystrophy in Japan.

Ishigaki K, Ihara C, Nakamura H, Mori-Yoshimura M, Maruo K, Taniguchi-Ikeda M, Kimura E, Murakami T, Sato T, Toda T, Kaiya H, Osawa M.

Neuromuscul Disord. 2018 Oct;28(10):885-893. doi: 10.1016/j.nmd.2018.08.001. Epub 2018 Aug 10.

PMID:
30220444
14.

Positive symptoms and time perception in schizophrenia: A meta-analysis.

Ueda N, Maruo K, Sumiyoshi T.

Schizophr Res Cogn. 2018 Aug 3;13:3-6. doi: 10.1016/j.scog.2018.07.002. eCollection 2018 Sep.

15.

Factors that promote new or continuous participation in social group activity among Japanese community-dwelling older adults: A 2-year longitudinal study.

Nemoto Y, Nonaka K, Hasebe M, Koike T, Minami U, Murayama Y, Murayama H, Matsunaga H, Fukaya T, Kobayashi E, Maruo K, Fujiwara Y.

Geriatr Gerontol Int. 2018 Aug;18(8):1259-1266. doi: 10.1111/ggi.13457. Epub 2018 Jul 12.

PMID:
29998492
16.

Effect of heteroscedasticity between treatment groups on mixed-effects models for repeated measures.

Gosho M, Maruo K.

Pharm Stat. 2018 Sep;17(5):578-592. doi: 10.1002/pst.1872. Epub 2018 Jul 6.

PMID:
29978944
17.

A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.

Kokubo N, Yokoi Y, Saitoh Y, Murata M, Maruo K, Takebayashi Y, Shinmei I, Yoshimoto S, Horikoshi M.

BMC Psychiatry. 2018 Jul 5;18(1):220. doi: 10.1186/s12888-018-1795-7.

18.

Attentional bias modification alters intrinsic functional network of attentional control: A randomized controlled trial.

Hakamata Y, Mizukami S, Komi S, Sato E, Moriguchi Y, Motomura Y, Maruo K, Izawa S, Kim Y, Hanakawa T, Inoue Y, Tagaya H.

J Affect Disord. 2018 Oct 1;238:472-481. doi: 10.1016/j.jad.2018.06.018. Epub 2018 Jun 5.

PMID:
29929157
19.

Analysis of risk factors for mild cognitive impairment based on word list memory test results and questionnaire responses in healthy Japanese individuals registered in an online database.

Ogawa M, Sone D, Maruo K, Shimada H, Suzuki K, Watanabe H, Matsuda H, Mizusawa H.

PLoS One. 2018 May 17;13(5):e0197466. doi: 10.1371/journal.pone.0197466. eCollection 2018.

20.

Conditional estimation using prior information in 2-stage group sequential designs assuming asymptotic normality when the trial terminated early.

Shimura M, Maruo K, Gosho M.

Pharm Stat. 2018 Sep;17(5):400-413. doi: 10.1002/pst.1859. Epub 2018 Apr 23.

PMID:
29687592

Supplemental Content

Loading ...
Support Center